Intellia Therapeutics (NASDAQ:NTLA) fell ~9% in the pre-market on Thursday after the biotech announced data from an ongoing ...
What keeps some immune systems youthful and effective in warding off age-related diseases? In new research done on mice, scientists point the finger at a small subset of blood stem cells, which make ...
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with ...
The promise of a one-and-done CRISPR infusion is beginning to look more real than ever. On Thursday, Intellia ...
Intellia Therapeutics has taken another step toward its goal of winning the first approval for an in vivo CRISPR therapy, ...
Contributing Writer for The Prospect Lily Hutcheson reflects on her fall break in London for a freshman seminar.
When the scientists used CRISPR to edit out these genes, blood stem cells reversed their natural tendency and produced more innate immune cells instead of adaptive immune cells-;like in the early ...
The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...
Charting the "dark matter" of the viral universe has implications not just for biotechnology—but potentially for battling the ...
We took a look around the SfN 2024 poster hall, picking our favorite posters and those we thought our audience would be most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback